Nitrated Lipids Mitigate Chemotherapy Toxicity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chemotherapy and radiotherapy, while effective in treating cancer, often cause severe side effects such as organ system damage, nausea, vomiting, and hair loss due to their toxicity, which limits their clinical use and involves multifactorial mechanisms including oxidative stress and apoptosis.
Innovation Solution
Administration of nitrated lipids, specifically nitrated fatty acids or their esters, to mitigate side effects by reducing oxidative stress and apoptosis in organ systems, thereby alleviating damage caused by toxic medical therapies like chemotherapy and radiotherapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotherapy or radiotherapy is administered to treat cancer, then cancer treatment effectiveness is improved, but toxicity to normal tissues increases causing severe side effects
Solution Approach 1:
Nitrated lipids serve as an intermediary substance that mediates between the toxic medical therapy and normal tissues. The nitrated lipids are administered to patients undergoing chemotherapy or radiotherapy to protect normal tissues from damage while allowing the cancer treatment to proceed effectively. This intermediary approach resolves the contradiction by introducing a protective agent that specifically mitigates toxicity without interfering with the anti-cancer mechanism.
Solution Approach 2:
The invention converts the harmful oxidative stress and toxic effects into a beneficial protective mechanism. Nitrated lipids are administered to induce protective nitrosylation reactions that counteract the harmful oxidative damage caused by chemotherapy and radiotherapy. The harmful oxidative stress is thus transformed into a beneficial protective response through the introduction of nitrated lipids, allowing effective cancer treatment without severe side effects.
2Productivity
If the dose of toxic medical therapy is increased to improve cancer treatment outcomes, then treatment efficacy is improved, but severity of side effects increases
Solution Approach 1:
Nitrated lipids are administered in advance or concurrently with toxic medical therapy to establish protective mechanisms before the full toxic effect occurs. This preliminary protective action allows the subsequent administration of higher doses of chemotherapy or radiotherapy without proportionally increasing side effects, thus improving treatment efficacy while controlling toxicity.
Solution Approach 2:
The invention changes the chemical parameter of the treatment system by introducing nitrated lipids with specific nitro groups that modify the oxidative stress profile. This parameter change allows for increased dosage of toxic therapy while maintaining acceptable side effect levels, as the nitrated lipids alter the chemical environment to be more tolerable for normal tissues.
3Reliability
If nitrated lipids are administered to reduce oxidative stress, then protection from organ damage is improved, but the mechanism of action involves complex biochemical pathways
Solution Approach 1:
Nitrated lipids utilize the body's existing biochemical pathways for nitric oxide metabolism and lipid peroxidation to achieve protection. Rather than requiring complex external delivery systems or artificial mechanisms, the nitrated lipids are metabolized by endogenous enzymes and participate in natural cellular redox reactions. This self-service approach allows effective organ protection through relatively simple administration despite the complex underlying biochemical interactions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Nitrated lipids, such as 9-nitrooleic acid, effectively reduce or eliminate side effects by improving renal function, morphology, and reducing biomarkers of oxidative stress and apoptosis, as demonstrated in mouse models and human cell cultures, indicating their potential in managing chemotherapy-related toxicity.
Implementation Method 1
The mechanism of cisplatin-induced organ damage has been shown to be multifactorial, involving oxidative stress and apoptosis
Implementation Method 2
The mechanism of cisplatin-induced organ damage has been shown to be multifactorial, involving oxidative stress and apoptosis
Data Source
AI summary
The present invention relates to methods of treating the side effects of a toxic medical therapy using nitrated lipids. In particular, the methods comprise the use of nitrated fatty acids or esters thereof to treat side effects, including organ system damage, caused by chemotherapy, radiotherapy, and the administration of other toxic agents.